ETON stock news
This page provides real-time market news, earnings updates, and company announcements related to Eton Pharmaceuticals, Inc. (ETON).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-04 21:55 EST
Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA (desmopressin acetate) Oral Solution
Finviz2026-02-25 18:51:43
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL (propranolol hydrochloride) Oral Solution
Finviz2026-03-02 12:30:57
Eton Pharmaceuticals, Inc. has signed a licensing agreement to successfully acquire the exclusive U.S. marketing rights for Hemangeol oral solution from Pierre Fabre Medicament Sas.
老虎证券2026-03-02 12:42:08
Eton Pharmaceuticals, Inc. announced that, in addition to the acquisition of core assets, the company also plans to purchase approximately $1.5 million worth of inventory products at the time of transaction closing.
老虎证券2026-03-02 12:42:14
ETON stock chart
ETON stock detailsETON stock price change
On the last trading day, ETON stock closed at 17.98 USD, with a price change of 3.04% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more